نتایج جستجو برای: 131i

تعداد نتایج: 2017  

Journal: :Nuklearmedizin. Nuclear medicine 2011
F A Verburg M Luster M Lassmann C Reiners

UNLABELLED Due to its excellent tolerability and low incidence of side effects, 131I therapy has been the treatment of choice for benign thyroid diseases for over 60 years. A potentially increased risk of malignancies due to this therapy is however still subject of debate. AIM To review the literature pertaining to 131I therapy of benign thyroid diseases in order to establish whether there is...

Journal: :Kaku igaku. The Japanese journal of nuclear medicine 2005
Katsumi Hayashi Katsumi Abe Ikuko Sakata Chiharu Sakaguchi Kentaro Yamamoto Shigeru Kosuda

There is no comparative cost-utility study between 131I therapy and antithyroid drugs (ATD) therapy for Graves' disease, though 131I therapy has higher remission rate and less side effects. The objective of the study was to analyze the cost-utility of ATD therapy versus 131I therapy by calculating life-long medical costs and utility, based on the responses of Graves' disease patients to questio...

Journal: :Cancer research 1988
G Bruchelt R Girgert J Buck H Wolburg D Niethammer J Treuner

As we have reported recently, the human neuroblastoma cell line SK-N-SH is able to take up and store m-iodobenzylguanidine (mIBG). This is in contrast to several other neuroblastoma cell lines, among which are SK-N-LO cells. Both cell lines were used in cell killing experiments with unlabeled and radioactive-labeled mIBG. Using 1-200 microCi m-[131I]IBG (1 h incubation time), only SK-N-SH cells...

Journal: :Cancer research 1987
R M Sharkey M J Pykett J A Siegel E A Alger F J Primus D M Goldenberg

We have investigated the therapeutic efficacy of a single injection of 131I-labeled murine mouse monoclonal antibody (NP-4) against carcinoembryonic antigen using the human colonic tumor xenograft, GW-39, grown in the cheek pouches of adult hamsters. Therapeutic efficacy was dependent on the dose of radioactivity, the specificity of the antibody for the tumor, and the size of the tumor when the...

Journal: :Internal medicine 1994
Y Ozawa M Migita T Watanabe I Okuda A Takeshita A Takagi Y Shishiba

HTLV-I carriers or patients with HTLV-I associated myelopathy (HAM) are prone to immune-mediated inflammatory disorders. We present a 44-year-old female with HAM who developed Graves' disease. She developed severe Graves' ophthalmopathy shortly after 131I therapy, concurrently with a remarkable increase in TSH-receptor antibody titer. Ophthalmopathy was aggravated in spite of prednisolone thera...

2017
Dom-Gene Tu Yu-Ling Lin

However, we would like to question whether there may be typographical errors in the article. On page 137, in line 10 of the right column, the amount of 131I is given as 54 μCi. On page 138, in line 18 of the left column, the amount of 131I is given as 49 μCi. Moreover, on page 138, in line 14 of the right column, the amount of 131I is given as 49 μCi. We would like to question whether the unit ...

Journal: :The British journal of radiology 2004
N Nair S Basu H Pakhale

A wide spectrum of potentially misleading artefacts can arise in 131I whole body scans from various anatomical variants and physiological processes as well as several unrelated non-thyroidal disease processes. A proper understanding of the causes of false positive 131I scans is essential for accurate interpretation of the images and to obviate diagnostic errors which may lead to administration ...

Journal: :Clinical medicine 2003
Mark Aitken Ajith George Charles Bodmer John Cameron

Between 1999 and June 2001, 55 unselected thyrotoxic patients were prescribed 200 MBq radioactive iodine (131I). None of these patients received a thionamide such as carbimazole or propylthiouracil within two weeks of treatment or subsequently. Symptom relief was achieved using beta blockers alone. Remission at one year was achieved in 84% of these patients and of these 62% were hypothyroid and...

Journal: :Japanese journal of medicine 1990
Y Nakagami K Nomura K Kusakabe N Miko T Tsushima H Demura

A 47-year-old man had surgery for paraaortic paraganglioma in 1980 and 1985. In 1987, his urinary excretion of catecholamines and metabolites was extremely high. Scintigraphy with 131I-metaiodobenzylguanidine (MIBG) showed multiple bone and liver metastases. He was treated twice with infusions of 3.7 GBq of 131I-MIBG. After the first treatment, he had transient hypertension and pain in the back...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید